Milwaukee, Wisconsin
August 2, 2006
EMD Crop BioScience
announces its new corporate name and logo. Following Nitragin’s
acquisition of Agribiotics, the two have combined as one entity
now known as EMD Crop BioScience. EMD Crop BioScience is a
subsidiary of Merck KGaA’s North American EMD Group and is
recognized as a core business focusing on plant health research
and commercialization of cropenhancing technologies.
“We are looking forward to
continuing to provide growers with our successful line of early
plant health products while introducing innovative new
technologies to the market during this exciting time at EMD Crop
BioScience,” says President Tom Winkofske.
In March 2006, Nitragin Holding,
Inc. acquired Cambridge, Ontario-based Agribiotics Inc. The
acquisition resulted in several additions to Nitragin’s
portfolio of crop-enhancing technologies and the ability to
commercialize a variety of yield-increasing technologies in a
number of markets. The home offices and manufacturing facilities
of the heritage organizations in Milwaukee, Wisconsin, and
Cambridge, Ontario, will continue operations under the name EMD
Crop BioScience. As a result of the integration, EMD Crop
BioScience will enjoy an increased field presence in both Canada
and the United States to better serve their customer base.
As result of its commitment to
leadership in the commercialization of crop-enhancing
technologies, EMD Crop BioScience has produced a number of
revolutionary products that focus on early plant health. EMD
Crop BioScience anticipates the introduction of crop-enhancing
products that contain the patented LCO Promoter Technology™, a
natural, biological molecule, and other technologies for use on
corn, cotton, wheat and tomatoes. Several other crops will
follow in the upcoming years.
“LCO Promoter Technology is an
effective, innovative technology that is producing an increase
in early plant health and yield in a number of legume crops,”
says Scott Fleetwood, Ph.D., Vice President of Sales and
Marketing for EMD Crop BioScience. “Commercializing this
technology for non-legumes will be a very significant stride in
early plant health technology and EMD Crop BioScience is proud
to lead this effort.”
“As our world continues to grow,
it becomes increasingly important for growers to receive maximum
yield from every acre that is planted,” says Winkofske.
“Everyone at EMD Crop BioScience is committed to partnering with
farmers to make products that enable them to be as productive as
possible.”
Originally founded as the
Nitragin Company in 1898 after a Milwaukee entrepreneur
purchased rights to a commercial process for the production of
nitrogen-fixing rhizobia. Nitragin remained privately owned
until 1982. In 1991 Merck KGaA, Darmstadt, Germany purchased the
business. Now headquartered in Milwaukee, Wisconsin, EMD Crop
BioScience is committed to advancing crop-enhancing technologies
and making these products available to growers worldwide.
Merck is a global
pharmaceutical and chemical enterprise with sales of € 5.9
billion in 2005, a history that began in 1668, and a future
shaped by 29,958 employees in 55 countries. The 1917 the U.S.
subsidiary Merck & Co. was expropriated and has been an
independent company ever since. |